|
(b)(4) date sent to the fda: 4/12/2021.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Additional information: d4, d9, h4, h6 a manufacturing record evaluation was performed for the finished device lot number qpmbbm, and no non-conformances related to the reported complaint condition were identified h6 component code: g07002 ¿ conforming device additional h3 investigation summary: the product was returned for evaluation.Visual inspection evaluation was conducted on the returned device.Visual analysis of the returned sample determined that one sealed box (36 ea) of product code mcp3040h was received for evaluation.Visual inspection of the sealed box and no defects were observed, the box was opened and thirteen unopened samples were opened, the suture belong to violet monocryl 4-0¿ in diameter, length 70 cm with a visi-black needle rb-1 plus correct for the product code mcp3040h.Further evaluation was performed into the system and the component assigned are correct needle rmc rb01182741pb, the b indicates that the needle is black, and suture rmc 861042 belongs to monocryl violet 4-0 27¿.As part of our quality process, the manufacturing records of this lot-serial number were reviewed, and the manufacturing standards were met prior to the release of this batch.The event described could not be confirmed as the device performed without any defect noted.Pc-000858514 date sent to the fda: 4/12/2021.
|